Business & Management
Global

Business & Management Experts

David Guyer


BOARD OF DIRECTORS
Sound Pharmaceuticals
United States of America

Biography

Dr. Guyer is the Co-Founder, Chairman, and CEO of Ophthotech (NASDAQ:OPHT) and has lead its financing strategy since its inception in 2007. In addition to taking OPHT public, Dr. Guyer co-founded and served as CEO and Director at Eyetech Pharmaceuticals (NASDAQ:EYET), where he led the company through private and public financings totaling over $400 million. David oversaw the development of Macugen, the first FDA-approved anti-VEGF treatment for wet AMD. EYET reached a peak market capitalization of approximately $2 billion as was later sold to OSI Pharmaceuticals in 2005. Prior Opthotech, David was a Venture Partner at SV Life Sciences and Professor and Chairman of Ophthalmology at New York University School of Medicine.

Research Interest

BUSINESS AND MANAGEMENT

Global Experts from United States of America

Global Experts in Subject

Share This Profile